Protective role of remogliflozin against experimental liver fibrosis by activating AMPK/SIRT1/Nrf2 and suppressing NF-κB pathways

Naif Alsuhaymi(Umm al-Qura University), Marawan A. Elbaset(National Research Centre), Mahdi H. Alsugoor(Umm al-Qura University), Reda M. S. Korany(Cairo University), Hany M. Fayed(Institute of Clinical Research), Bassim M. S. A. Mohamed(National Research Centre), Sherif M. Afifi(University of Sadat City), Aya A. Shokry(Cairo University), Tuba Esatbeyoglu(Gottfried-Wilhelm-Leibniz-Gesellschaft)
Frontiers in Pharmacology
June 9, 2025
Cited by 10


Related Papers